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ABSTRACT 
 
Characterization of the Fecal Microbiota in Dogs with Chronic Enteropathies and Acute 
Hemorrhagic Diarrhea. (August 2012) 
Melissa Ellen Markel, B.A., Austin College; 
B.S. Texas A&M University 
Chair of Advisory Committee: Dr. Jan S. Suchodolski 
 
 Recent 16S rRNA gene sequencing studies of the duodenal and fecal microbiota 
have revealed alterations in the abundance of specific bacterial groups in dogs with 
gastrointestinal (GI) disorders. The aim of this study was to establish a panel of 
quantitative real-time PCR (qPCR) assays for the evaluation of specific bacterial groups 
in fecal samples of healthy dogs, dogs with chronic enteropathies (CE), and dogs with 
acute hemorrhagic diarrhea (AHD). Fecal samples from 242 healthy dogs, 118 dogs with 
CE, and 57 dogs with AHD were analyzed using qPCR assays targeting 
Faecalibacterium spp., Turicibacter spp., Bifidobacterium spp., Lactobacillus spp., 
Streptococcus spp., Ruminococcaceae, C. perfringens, E. coli, γ-Proteobacteria, 
Bacteroidetes, and Firmicutes). Differences in bacterial abundance among the three 
groups were evaluated using a Kruskal-Wallis test followed by a Dunn’s post-test. A 
Bonferroni correction was used to correct for multiple comparisons and an adjusted 
p<0.05 was considered for statistical significance. 
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 Faecalibacterium spp., Turicibacter spp., and Ruminococcaceae were 
significantly decreased in CE and AHD compared to healthy dogs (p<0.001 for all). 
Lactobacillus spp. and Streptococcus spp. were significantly increased in dogs with CE 
(p<0.001 for both) when compared to the healthy dogs. In contrast, Lactobacillus spp. 
and Streptococcus spp. were significantly decreased in dogs with AHD compared to 
healthy dogs (p<0.01 and p<0.05, respectively) and also when compared to the dogs 
with CE (p<0.001 for both). C. perfringens and E. coli were significantly increased in 
dogs with AHD (p<0.001 and p<0.01, respectively), when compared to healthy dogs. E. 
coli was also significantly increased in dogs with CE when compared to the healthy dogs 
(p<0.001). Bacteroidetes were significantly lower in dogs with CE compared to healthy 
dogs (<0.001). Firmicutes were significantly higher in healthy dogs in comparison to 
dogs with AHD (p<0.05). Bifidobacterium spp. and γ-Proteobacteria were not 
significantly different among all three groups of dogs. 
 In conclusion, the qPCR panel employed here revealed a fecal dysbiosis in dogs 
with CE and AHD when compared to healthy dogs. These results are similar to recently 
reported findings using molecular sequencing approaches. Quantification of these 
bacterial groups by qPCR may be a useful adjunct for the diagnosis or monitoring of 
gastrointestinal disease in dogs. 
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CE chronic enteropathies 
AHD acute hemorrhagic diarrhea  
GI gastrointestinal 
qPCR quantitative real-time polymerase chain reaction 
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CHAPTER I 
INTRODUCTION AND 
LITERATURE REVIEW 
 
THE EFFECT OF THE MICROBIOTA ON GASTROINTESTINAL HEALTH 
 It has been suggested that microbes in the gastrointestinal tract (GI) play a 
significant role in maintaining host health [1,2]. The beneficial effects of the GI 
microbiota on the host include their crucial role in the structural development of the 
intestinal epithelium, the stimulation of the immune system, and provision of nutritional 
support for the host [3-8]. This has been supported by data in germ free mice that exhibit 
a blunted development of lymphoid tissue [9], have smaller Peyer’s patches and 
mesenteric lymph nodes, and a reduced turnover time of epithelial cells compared to 
conventionally raised mice [4,10,11]. The intestinal microbiota produces various 
metabolites that provide benefits to the host [6-8,12-15]. These include short-chain fatty 
acids (i.e., acetate, propionate, and butyrate). Short-chain fatty acids, especially butyrate, 
have been shown to have anti-inflammatory properties [8]. An increased concentration 
of short-chain fatty acids leads to a lower luminal pH in the intestine which may prevent 
the overgrowth of pH-sensitive pathogenic bacteria [6]. Vitamins, such as vitamin K, 
cobalamin (B12), thiamine (B1), folate (B9) and riboflavin (B2) are also produced by the 
intestinal microbiota. Vitamin K can produced by some lactic acid bacteria and is 
involved in blood clotting [12].  Bifidobacterium spp. have been reported to produce  
____________ 
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riboflavin and thiamine. Deficiency in these vitamins may lead to changes in brain 
glucose metabolism [16]. Folate is an essential vitamin involved in nucleotide and 
cofactor biosynthesis, and in many metabolic reactions [12]. Cobalamin is important for 
the metabolism of amino acids, carbohydrates, and fatty acids [17]. Intestinal microbiota 
may also protect the host from pathogenic bacteria by means of competitive exclusion 
[12,18]. This is achieved for example through the synthesis and release of 
antimicrobials, competition for oxygen or mucosal adhesion sites, or through the 
creation of a physiologically hostile environment for potentially pathogenic bacteria 
(e.g., alteration of luminal pH) [12,19-21]. 
 
 
 
 
CHARACTERIZATION OF THE INTESTINAL MICROBIOTA 
 An accurate characterization of the intestinal microbiota is imperative for the 
identification of altered microbial populations (i.e., dysbiosis) that may be present in 
dogs with GI disease. The two main methods for bacterial identification are through the 
use of culture and molecular-based methods. 
 Culture-based methods. Characterization of bacteria present within the GI tract 
is critical for our understanding of the role of the microbiota in host health and disease. 
Traditionally, culture-based methods have been used to characterize the bacterial 
populations of the GI tract [11,22-24]. Some authors have estimated that approximately 
10-50% of fecal bacterial genera present in the mammalian GI tract can be cultured [25]. 
In contrast, other authors have suggested that more than 99% of prokaryotes in most 
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environmental samples are uncultivable [26]. It is well accepted that there are limitations 
to traditional culture-based methods when analyzing complex microbial ecosystems such 
as the mammalian GI tract [27,28]. Only a portion of bacteria present in the GI tract can 
be cultured, mostly due to unknown growth requirements for many gastrointestinal 
bacteria, stress due to cultivation procedures (e.g., some bacteria require strictly 
anaerobic conditions), and the difficulties simulating symbiotic relationships with other 
microbes and/or the host in- vitro [25]. Due to restrictive growth environments, many 
gut microbes have not been sufficiently characterized and, therefore, the commonly 
employed biochemical tests may be insufficient for correct classification of some 
microbial phylotypes [25,29].  
 Molecular-based methods. To evaluate the diversity of bacterial groups, it is 
necessary to consider genes that have been conserved over the course of evolution. The 
current standard approach to characterize the intestinal microbiota is through molecular-
based methods, specifically through sequencing of the 16S rRNA gene [21,30-34]. The 
16S rRNA gene can be found in all prokaryotes and is widely used due to its unique 
properties such as ubiquity, presence of hypervariable regions (where sequences have 
been modified over the course of evolution for specific bacterial groups), and the 
presence of highly conserved regions that are shared among most bacterial phylotypes 
[35,36]. Polymerase chain reaction (PCR) primers are designed to anneal to regions 
within the bacterial DNA, and depending on which bacterial groups are of interest, will 
target either highly conserved or the variable regions within the 16S rRNA gene [37]. 
There are several molecular tools available by which microbiota can be analyzed, 
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including molecular fingerprinting techniques, fluorescent in situ hybridization (FISH), 
quantitative real-time PCR (qPCR), and sequencing technologies (e.g., 454-
pyrosequencing or, Sanger sequencing of 16S rRNA gene clone libraries). 
Polymerase Chain Reaction (PCR). For most molecular-based methods, PCR is 
initially used to amplify parts of the 16S rRNA gene [38-41]. Primers are designed to 
target either conserved or hypervariable regions in this gene, depending on which 
bacterial groups are of interest. Universal bacterial primers target the conserved regions 
of the 16S rRNA gene and, in theory, allow amplification of the 16S rRNA genes of all 
bacteria present in a given sample. In contrast, to identify specific bacterial groups (on 
various phylogenetic levels), PCR primers are designed to target more variable regions 
of the 16S rRNA gene.  
The use of quantitative PCR assays (qPCR) allows determination of the 
abundance of bacteria in a given sample. Unlike conventional PCR, qPCR assays allow 
for the amplified DNA to be detected as the reaction progresses in real time. These 
assays use either the intercalation of non-specific fluorescent dyes (e.g., SybrGreen®) 
into double-stranded DNA of the target sequence, or fluorescent labeled probes 
(Taqman® PCR assays) to quantify the abundance of bacterial groups [30]. This 
quantification corresponds to the increasing level of fluorescence, which is associated 
with a higher abundance of double stranded DNA. In Taqman® PCR assays, a 
fluorescent labeled probe is used. The probe consists of a fluorophore that is covalently 
bound to the 5’-end of the probe and a quencher which is bound to the 3’-end. When in 
close proximity, the quencher suppresses the fluorescence of the fluorophore. During the 
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PCR assay the probe first binds to the template DNA strand.  During the PCR extension, 
the polymerase synthesizes the complementary strand and degrades the probe. This 
degradation releases the fluorophore from the quencher, and the resulting fluorescence 
of the fluorophore is detected by the camera of PCR thermal cycler.  Increased intensity 
of the released fluorophore directly correlates to the amount of DNA product present in 
the PCR [42-44].  
Real-time PCR has many advantages such as high analytical sensitivity, high 
reproducibility, and minimal time requirement. Real-time PCR is a closed-tube system 
that requires no post-PCR manipulation, therefore reducing any potential for 
contamination [45,46]. There are some disadvantages of PCR-based methods. For 
example, the efficiency of the PCR assay is reflective of the oligonucleotide primer 
design; if the oligonucleotide primers are not specific for the targeted bacterial group, 
the PCR assay will result in amplification of an undesired target sequence and 
potentially false positive results. PCR is also susceptible to inhibition by compounds 
found within the sample matrix, including excess salts, ionic detergents, and ethanol 
which can lead to false negative results. Finally, there is a relatively high cost for initial 
equipment set-up and reagents [47]. 
Molecular fingerprinting techniques. The purpose of molecular fingerprinting 
techniques is to characterize bacterial diversity in a complex microbial community 
[48,49]. With this technique, a region of the 16S rRNA gene is amplified, followed by 
electrophoretic separation of the resulting PCR amplicons on gel electrophoresis, such as 
for example denaturing gradient gel electrophoresis (DGGE) [49,50]. This technique 
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allows for rapid and inexpensive comparison of microbiota profiles among samples [51-
53]. However, DGGE has a limited resolution and will only display DNA fragments 
from predominant species present in the sample [51]. Furthermore, for the identification 
of bacterial groups, DGGE bands need to be excised from the gel, which is time 
consuming and laborious [50]. 
Fluorescent In Situ Hybridization (FISH). FISH utilizes fluorescent labeled 
probes that target the bacterial 16S rRNA and is often used for the identification of 
specific bacterial groups in body fluids, tissue biopsies, or fecal samples [30,54-56].  
Methods by which tissue or fecal samples are being evaluated require the sample to be 
fixed prior to FISH. Formalin-based fixatives are most commonly used in this process. 
Fixed samples are then generally mounted in paraffin wax in order to provide support for 
subsequent sectioning for microscopic evaluation. Fixed samples are dehydrated and 
rehydrated to increase permeabilization by means of breaking down protein-DNA 
crosslinks. Increased permeabilization facilitates the entry of the probe into the cell so 
that it may link to the intended nucleotide target sequence. Once samples have been 
prepared for hybridization, an oligonucleotide probe, which is tagged with a fluorescent 
label is applied [56]. The probe then hybridizes to the complementary oligonucleotide 
sequence, and the fluorescence can be visualized using a fluorescence microscope [57]. 
FISH can be limited by the specificity of the hybridization of the probe. Hybridization of 
the probe to the intended nucleotide target sequence can be altered during sample 
preparation, which can lead to decreased detection of the target nucleotide. If the probe 
binds incorrectly, the observer may misinterpret the fluorescence as being the intended 
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nucleotide target sequence, when the signal is actually being emitted from a nucleotide 
sequence that was bound non-specifically and that does not correspond to the bacterial 
group of interest [54]. FISH is also limited by laborious sample preparation [56]. 
Currently, interpretation of FISH assays relies on individual observers interpreting the 
fluorescence signal as being positive or negative, which can lead to errors between 
observers [54]. 
454-pyrosequencing of the 16S rRNA gene. 454-pyrosequencing is a high-
throughput sequencing technology that allows the in-depth characterization of bacterial 
groups present in the gastrointestinal tract using multiplex analysis. This technique is 
advantageous because it allows for paralleled generation of DNA sequences from a large 
number of samples simultaneously. Additionally, low concentrations of template DNA 
are suitable for quantification [58]. However, there are disadvantages associated with 
454-sequencing. Some 16S rRNA sequences such as Bifidobacterium spp., are typically 
detected at a reduced abundance. This can be due to the lack of mechanical force 
sufficient to lyse the cell walls of these bacteria or could be due to the relatively high 
G+C content in bifidobacterial sequences [59]. Sequences rich in guanine (G) and 
cytosine (C) can be difficult to denature due to the three hydrogen bonds connecting the 
base pairs [58]. Additionally, this sequencing technology requires costly equipment and 
performance of the methods is also costly [60]. 
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THE CANINE INTESTINAL MICROBIOTA 
 Previous studies have used a variety of traditional methods to characterize the 
microbiota of the intestinal tract in humans and animals [27,32,61-63]. Molecular 
methods have been employed to allow for a more detailed characterization of microbial 
populations in the GI tract of dogs and humans [28,32,64,65]. 
 In one study, intestinal contents were collected from the duodenum, jejunum, 
ileum, colon, and rectum of dogs [49]. Bacterial DNA was extracted from each 
respective sample, and subjected to PCR in which a variable region of the 16S rRNA 
gene was amplified using universal bacterial primers. Amplicons were separated using 
DGGE. Banding patterns were analyzed to compare differences in the microbiota among 
the various intestinal regions and also between dogs. This molecular approach 
demonstrated the presence of a complex intestinal microbial community in the canine 
intestine, which not only varies depending upon intestinal compartments, but also among 
dogs. It has been suggested that due to the varied bacterial populations among 
compartments, the analysis of fecal samples may not yield accurate information 
regarding bacterial population composition within the more proximal GI system of dogs 
[49]. 
 Another study evaluated differences in the microbiota between the small intestine 
and fecal samples in dogs [64]. Jejunal chyme and fecal samples were obtained from 22 
healthy laboratory Beagle dogs. Samples were homogenized, diluted, and cultured in an 
aerobic and also anaerobic environment. Bacterial counts in the jejunum were 
dramatically lower (range: 102 to 106 CFU/g) than in feces (range: 108 to 1011 CFU/g). 
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Also, the mean number of identified bacterial genera was lower in the small intestine 
(range: 1 to 11) than in feces (range: 9 to 16). Approximately 25% of bacteria detected in 
the small intestine could not be identified in the corresponding fecal sample, while 45% 
of bacteria found in the fecal samples were not detectable in small intestinal samples. 
Microbial groups that were more prevalent in the small intestine were Staphylococcus 
spp. (64% vs. 36% in feces) and non-fermentative gram negative bacilli (e.g., 
Pseudomonas spp. (27% vs. 9% in feces). The microbial groups that dominated the fecal 
microbiota, such as Bacteroides spp., Clostridium hiranonis-like organisms, and 
Lactobacillus spp. were practically absent from the jejunum [64].  
 One study described the intraluminal intestinal microbiota in dogs using 16S 
rRNA gene sequence analysis [66]. Luminal content was collected from the duodenum, 
jejunum, ileum, and colon from 6 healthy dogs. Bacterial DNA was extracted and 
subjected to PCR in which the bacterial 16S rRNA gene was amplified using universal 
bacterial primers. Resulting amplicons were ligated into cloning vectors and 16S rRNA 
gene inserts were sequenced. Four bacterial phyla were identified: Firmicutes (34% of 
clones), Fusobacteria (12%), Bacteroidetes (9%), and Proteobacteria (17%). The order 
Clostridiales was found to be the most abundant and diverse bacterial order in the 
duodenum and jejunum, with 40% and 39% of identified clones, respectively. The 
proximal small intestine and colon were dominated by sequences affiliated with 
Clostridium cluster XI and Clostridium cluster XIVa, respectively. The most abundant 
bacterial orders of the ileum and colon were Fusobacteriales and Bacteroidales, with 
33% and 30% of clones, respectively  [66].  
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 Handl et al. [63] evaluated the fecal microbiota of 12 healthy pet dogs using 454-
pyrosequencing of the 16S rRNA gene. Firmicutes were the most abundant phylum, 
with 95.36 ± 5.19% of all sequences belonging to this phylum. Bacteroidetes was the 
second most abundant phylum (2.25 ± 5.37% of all bacterial sequences). Furthermore, 
69.35 ± 18.45% of bacterial sequences belonged to the class Clostridia, predominately to 
the genera Clostridium (22.73 ± 15.46%) and Ruminococcus (17.37 ± 11.18). As 
described in a previous study by Suchodolski, et al. (2008), the most prevalent 
Clostridium clusters were cluster XIVa (59.59 ± 23.2% of all Clostridiales sequences), 
and cluster XI (33.64 ± 17.13% of all Clostridiales sequences) [63].  
Middlebos et al. [65] evaluated changes in the fecal microbiota in response to 
fiber supplementation in 6 healthy adult dogs using 454-pyrosequencing of the V3 
hypervariable region of the 16S rDNA gene. Dogs were fed a control diet without fiber 
supplementation and a beet pulp-supplemented diet (7.5%). The complete dataset 
included 77,771 sequencing reads and individual samples contained approximately 129 
operational taxonomic units (OTUs; range: 113-147 OTUs). Three co-dominant phyla 
were observed: Fusobacteria (23-40% of reads), Firmicutes (14-28%), and 
Bacteroidetes (31-34%). Fiber supplementation yielded modifications of the intestinal 
microbiota, however these alterations were not equally apparent in all dogs. The 
abundance of Actinobacteria (1.4-0.8%) and Fusobacteria (40-24%) was lower (P<0.05) 
in dogs fed the beet pulp diet. Abundance of Firmicutes (15-28%) was significantly 
increased in dogs fed the beet pulp diet (P<0.05). Clostridia was found to be the most 
dominant class in the phylum Firmicutes (≥82% of sequences) in both diets, and 
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significantly increased (83-90%) when dogs were supplemented with the beet pulp diet 
(P<0.05) [65]. 
The true bacterial abundances in the GI tract of dogs reported in those studies are 
difficult to compare due to various factors. It has been suggested that there are 
differences in the microbiota depending upon the sampling site [49]. Furthermore, 
differences in the microbiota based on sample type (e.g., chyme versus feces) have been 
demonstrated [64]. It is also possible that the methodology by which samples are 
analyzed may have an effect on bacterial characterization. For example, Yu and 
Morrison [67] have described a bead beating based bacterial extraction method, leading 
to a more complete lysis of bacterial cells, which resulted in better representation of 
microbial diversity in comparison to other bacterial extraction methods. All of these 
factors must be considered when comparing the reported abundance of microbial 
populations across studies.  
 
INTESTINAL MICROBIOTA IN DISEASE 
Bacterial dysbiosis has recently been associated with the pathogenesis of some 
gastrointestinal disorders, including inflammatory bowel disease in animals and humans 
[68-71].  
 Chronic enteropathies. Chronic enteropathies (CE) describe a range of chronic 
diseases of the intestines regardless of etiology or pathogenesis. Inflammatory bowel 
disease (IBD) describes a subset of chronic enteropathies, which are characterized by 
persistent or recurrent signs of GI inflammation [72]. Clinical signs of chronic 
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enteropathies are varied and nonspecific, the most common being weight loss, large 
intestinal dysfunction, diarrhea, and vomiting [69]. Simpson and Jergens [72] suggest 
that some clinical signs may assist in identifying a region of interest and a probable 
cause of disease. These signs include upper GI bleeding or ulceration, tenesmus, 
dyschezia, peripheral edema, or enteric protein loss [72]. The diagnosis of chronic 
enteropathies involves the integration of signalment, history, physical examination 
findings, diagnostic imaging, and histopathology of intestinal biopsies [69,72]. The 
diagnostic approach is described as first excluding parasitic agents, extraintestinal 
disorders, and intestinal structural abnormalities. Chronic enteropathies may also be 
categorized based on treatment response as food responsive, antibiotic responsive, or 
steroid responsive. 
There is mounting evidence to suggest that chronic enteropathies are the result of 
a disproportionate immune response to commensal bacteria [21,70,73]. Rodent models 
have implicated commensal enteric bacteria in chronic, immune-mediated colitis [70]. 
Chronic enteropathies have been associated with dysbiosis in dogs, more specifically a 
decreased abundance of gram-positive Firmicutes and an increased abundance of gram-
negative bacteria, such as Proteobacteria  [21,74,75]. One study described differences in 
the mucosa-adherent duodenal microbiota between dogs with idiopathic IBD and healthy 
dogs. Significant differences were identified in the relative abundance of several 
bacterial groups. Dogs with IBD had a significantly higher abundance of γ-
Proteobacteria (p<0.001), and a significantly lower abundance of Clostridia (p<0.001) 
[21]. Small intestinal microbial communities were described in one study in which 
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duodenal brush cytology samples were analyzed from 10 dogs with IBD. Sequences 
belonging to the phylum Bacteroidetes were significantly less common in dogs with IBD 
(2.7%) than healthy dogs (11.2%, p<0.001). Nearly half of the sequences from healthy 
dogs belonged to three orders Clostridiales (19.6%), Lactobacillales (14.1%), and 
Campylobacteriales (13.9%), whereas in the IBD group, the vast majority of sequences 
belonged to the orders Clostridiales (40.4%), Enterobacteriales (20.9%), and 
Lactobacillales (17.5%) [75]. In another study, dogs with antibiotic-responsive 
enteropathy have been associated with an increased abundance of Lactobacillales [76].  
 Simpson, et al. performed a study using fluorescent in-situ hybridization (FISH) 
and observed translocated E.coli in the epithelial cells of the colonic mucosa of Boxer 
dogs with granulomatous colitis [73]. Once the E. coli organisms are eradicated, the 
condition shifts into a remissive state [77,78].  
Acute hemorrhagic diarrhea. Many dogs present for veterinary care with an 
acute onset of hemorrhagic diarrhea (AHD). There are several potential causes of AHD, 
including infection with Campylobacter jejuni, Salmonella, Clostridium perfringens, C. 
difficile, and canine parvovirus infection [61,79-81]. Hemorrhagic gastroenteritis (HGE), 
is a subgroup of AHD commonly found in small breeds, which present with bloody 
watery stool, vomiting, and severe hemoconcentration. Due to the acute symptomology, 
it has been suggested that food allergy or bacterial endotoxins may play an active role in 
the pathogenesis of this syndrome [82]. The microbial communities present in dogs with 
AHD have not been well documented.  
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HYPOTHESIS AND SPECIFIC OBJECTIVES 
 The hypotheses of this study are that 1) qPCR can be used to characterize the 
fecal microbiota, and 2) that this qPCR approach can be used to identify a dysbiosis in 
dogs with CE and AHD. 
 The objectives of this study are 1) to establish a panel of qPCR assays to 
accurately identify specific bacterial groups within the canine fecal microbiota, 2) to 
characterize the fecal microbiota in healthy dogs, and 3) to compare the fecal microbiota 
of healthy dogs to that of dogs with CE and AHD.  
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CHAPTER II 
CHARACTERIZATION OF THE INTESTINAL MICROBIOTA IN HEALTHY 
DOGS AND DOGS WITH INTESTINAL DISEASE 
SUMMARY 
 The aim of this study was to evaluate the abundance of selected bacterial groups 
in healthy dogs, dogs with chronic enteropathies (CE), and dogs with acute hemorrhagic 
diarrhea (AHD). Fecal samples were collected from 242 healthy pet dogs, 118 dogs with 
CE, and 57 dogs with AHD. Bacterial DNA was extracted from all fecal samples and 
adjusted to a concentration of 5 ng/µl. Separate qPCR assays were performed to quantify 
eleven microbial groups. Sequences belonging to Faecalibacterium spp., Turicibacter 
spp., or Ruminococcaceae were significantly decreased in dogs with CE or AHD 
compared to healthy dogs (p<0.001 for all). Sequences belonging to Lactobacillus spp. 
or Streptococcus spp. were significantly increased in dogs with CE (p<0.001 for both) 
when compared to healthy dogs. In contrast, Lactobacillus spp. and Streptococcus spp. 
sequences were significantly decreased in dogs with AHD compared to healthy dogs 
(p<0.01 and p<0.05, respectively) and also the dogs with CE (p<0.001 for both).  C. 
perfringens and E. coli sequences were significantly increased in dogs with AHD 
(p<0.001 and p<0.01, respectively), when compared to healthy dogs. E. coli sequences 
were also significantly increased in dogs with CE when compared to the healthy dogs 
(p<0.001). Bacteroidetes sequences were significantly lower in dogs with CE compared 
to healthy dogs (<0.001). Firmicutes sequences were significantly higher in healthy dogs 
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than in dogs with AHD (p<0.05). Bifidobacterium spp. and γ-Proteobacteria sequences 
were not significantly different among the three groups of dogs. 
 In conclusion, the qPCR panel employed here revealed a fecal dysbiosis in dogs 
with CE and AHD when compared to healthy dogs. These results are similar to recently 
reported findings using molecular sequencing approaches. Quantification of these 
bacterial groups by qPCR may be a useful adjunct for monitoring the fecal microbiota in 
dogs with enteropathies. 
 
INTRODUCTION 
 Gastrointestinal microbes have been shown to play a significant role in intestinal 
health and disease [1,23]. They provide benefits to the host by stimulating the 
development of the intestinal epithelium, priming the host immune system, and 
providing nutritional support through the production of various vitamins and metabolites 
[3-8]. For example, germ free mice have been shown to have a diminished development 
of lymphoid tissue, smaller Peyer’s patches and mesenteric lymph nodes, and a reduced 
turnover time of intestinal epithelial cells in comparison to conventionally raised mice 
[4,9-11]. The intestinal microbiota is thought to protect the host from potentially 
pathogenic bacteria through the synthesis and release of antimicrobials, competition for 
oxygen or mucosal adhesion sites, and through the establishment of a hostile 
environment for pathogenic bacteria [12,18-21]. 
 Alterations of the intestinal microbiota have been implicated in various acute and 
chronic gastrointestinal diseases in humans and also in dogs [4,10,21,27,54,76,83-85]. 
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For example, recent studies of the proximal small intestinal microbiota have revealed a 
microbial dysbiosis of the luminal as well as the mucosa-adherent microbiota of dogs 
with idiopathic inflammatory bowel disease [21,70,73,76,78]. These dogs showed a 
decreased abundance of gram-positive Firmicutes and an increased abundance of gram-
negative bacteria, most prominently within the phylum Proteobacteria. Less information 
is available about the microbiota composition in the large intestine or feces of dogs with 
gastrointestinal disease. It has been shown that the microbial composition differs along 
the length of the GI tract, and fecal samples may not be fully representative of microbial 
communities present in the proximal parts of the intestine [49]. It is also unknown if the 
previously observed changes in the composition of the microbiota are specific for canine 
IBD or if such patterns of dysbiosis are also present in dogs with acute episodes of 
diarrhea.  
Previous studies have evaluated the fecal microbiota of dogs with diarrhea. Bell 
et al [83] used terminal restriction fragment polymorphism (T-RFLP) and qPCR to 
characterize the fecal microbiota in 8 pet dogs with acute episodes of diarrhea and five 
research dogs. During episodes of diarrhea, an increased abundance of C. perfringens 
was identified. Campylobacter spp. and Helicobacter spp. were identified as being 
present in 11 of 15 fecal samples on the day of onset of the first episode of diarrhea [83]. 
Another study evaluated the effects of dietary fiber supplementation on the fecal 
microbiota in 17 research Beagles (9 with chronic diarrhea and 8 healthy controls) using 
FISH and DGGE [85].  Bacteroidetes sequences were significantly increased (p<0.05) 
and Atopobium sequences significantly decreased (p<0.05) in dogs with chronic diarrhea 
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in comparison to healthy dogs following fiber supplementation. Furthermore, sequences 
belonging to Clostridium clusters I and II were significantly increased in dogs with 
chronic diarrhea during fiber supplementation (p<0.05) in comparison to healthy dogs 
[85]. Using pyrosequencing of the chaperonin 60 gene, sequences belonging to ε-
Proteobacterium were analyzed in healthy dogs (n=7) and dogs with unspecified 
diarrhea (n=9)  [84]. The microbiota of healthy dogs was predominantly composed of 
Bacteroidetes (50% of sequence reads), and Firmicutes  and  Proteobacteria (each 
phylum 25% of reads). Dogs with diarrhea had a Firmicutes/ Proteobacteria/ 
Bacteroidetes/ Actinobacteria ratio of 4:4:1:1, with Bacteroidetes being the only phylum 
that was significantly higher in abundance between the two groups of dogs (p<0.05) 
[84]. While these studies present evidence for a difference in the microbiota of dogs with 
diarrhea in comparison to healthy dogs, these studies either did not utilize sequencing 
based technologies [83,85], or evaluated only a small number of dogs with unspecified 
diarrhea [83-85]. More detailed studies evaluating fecal dysbiosis in a larger group of 
dogs and with better characterized gastrointestinal diseases are needed to understand the 
influence of the intestinal microbiota on gastrointestinal health. Therefore, the aim of 
this study was to establish a panel of qPCR assays and to evaluate the abundance of 
specific bacterial groups in fecal samples of healthy dogs, dogs with CE, and dogs with 
AHD.  
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MATERIALS AND METHODS 
 Sample collection. Naturally passed fecal samples were obtained from 242 
healthy dogs, 118 dogs with CE, and 57 dogs with AHD from nine different countries. 
All dogs participated in different studies and leftover fecal samples were utilized for this 
study. The protocol for sample collection was approved by the Clinical Research Review 
Committee of the College of Veterinary Medicine, Texas A&M University (CRRC#09-
06), the Ethics and Welfare Committee of the Royal Veterinary College, and the Royal 
Canin Internal Ethics Committee.  
Table 1. summarizes the characteristics of the dogs enrolled in this study. Samples were 
stored frozen at -80°C until analysis.  Extraction of DNA. All samples were 
homogenized for 90 sec (Stomacher 80, Seward Laboratory Systems, Inc., NY, USA). A 
100 mg aliquot of each fecal sample was aliquoted into a sterile 1.7 ml microtube 
(Sarstedt AG & Co., Nümbrecht, Germany) containing 150 μl of 0.1 mm zirconia-silica 
beads and 100 μl of 0.5 mm zirconia-silica beads (BioSpec Products Inc., OK, USA). A 
volume of 750 μl of lysis buffer from the Zymo Fecal DNA Mini Prep kit (Zymo 
Research Inc., CA, USA) was added to each sample. Tubes were placed vertically onto a 
homogenizer (FastPrep-24, MP Biomedicals LLC, OH, USA), and the mixture was 
homogenized for 1 min at 4 m/sec. The tubes were then centrifuged at 10,000 g for 1 
min at 23°C and the remainder of the DNA extraction was performed as suggested by 
the manufacturer (Zymo Fecal DNA Mini Prep kit, Zymo Research Inc., CA, USA). The 
concentration of fecal DNA was measured using the NanoDrop 1000 (Thermo Fisher 
Scientific Inc., DE, USA) and was adjusted to 5 ng/μl. 
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Table 1. Dogs enrolled in the study 
 Number Age (years) Breed Gender 
    AHD dogs enrolled in the study 
 1 2.0 Chihuahua F 
2 4.0 Berger Picard MC 
3 8.0 Mixed Breed FS 
4 4.0 Chinese Shar Pei FS 
5 1.0 German Shepherd Dog Mix M 
6 2.0 West Highland White Terrier F 
7 5.0 Labrador Retriever Mix MC 
8 6.0 Cairn Terrier FS 
9 3.0 Fox Terrier M 
10 7.0 Podenco Canario F 
11 12.0 Golden Retriever FS 
12 10.0 Afghan Hound FS 
13 12.0 Labrador Retriever Mix FS 
14 2.0 Mixed Breed MC 
15 1.0 Chihuahua FS 
16 12.0 Mixed Breed F 
17 2.0 German Shepherd Dog M 
18 2.0 Mixed Breed F 
19 5.0 German Shepherd Dog M 
20 4.0 Mixed Breed M 
21 11.0 Airedale Terrier MC 
22 4.5 Labrador Retriever M 
23 1.0 Cavalier King Charles Spaniel  F 
24 1.5 Parson Russel Terrier F 
25 2.5 Bayerischer Gebirgsschweißhund M 
26 5.0 Miniature Poodle Mix FS 
27 3.0 Labrador Retriever M 
28 16.0 West Highland White Terrier M 
29 16.0 Spitz M 
30 11.0 Hovawart Mix FS 
31 12.0 Berger Briard Mix MC 
32 2.5 Mixed Breed M 
33 2.5 Pekinese M 
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Table 1. continued 
Number Age (years) Breed Gender 
34 2.0 Yorkshire Terrier F 
35 10.0 Fox Terrier M 
36 6.0 Mixed Breed MC 
37 3.0 Flat Coated Retriever FS 
38 13.0 Yorkshire Terrier Mix F 
39 2.5 Labrador Retriever M 
40 1.0 Mixed Breed M 
41 5.0 Labrador Retriever MC 
42 1.0 Miniature Schnauzer FS 
43 3.0 Dachshund MC 
44 5.0 Labrador Retriever Mix (Labradoodle) FS 
45 4.0 Chihuahua M 
46 1.0 Chihuahua FS 
47 1.5 Rough Collie MC 
48 5.0 Tibetan Mastiff MC 
49 1.5 Beauceron FS 
50 0.2 Labrador Retriever Mix (Labradoodle) F 
51 2.0 Rat Terrier F 
52 2.0 Nova Scotia Duck Tolling Retriever M 
53 7.0 Mixed Breed FS 
54 3.0 German Hound FS 
55 3.0 Labrador Retriever FS 
56 1.0 Hungarian Vizsla FS 
        57 11.0 Yorkshire Terrier FS 
    
    CE dogs enrolled in the study 
  1 4.0 Belgian Shepherd Dog M 
2 3.0 Yorkshire Terrier M 
3 7.0 Cane Corso M 
4 4.0 Shih Tzu MC 
5 6.0 English Bulldog M 
6 3.0 Boxer F 
7 5.5 Yorkshire Terrier M 
8 8.5 German Shepherd Dog M 
9 4.0 German Shepherd Dog M 
10 3.0 Labrador Retriever F 
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Table 1. continued 
Number Age (years) Breed Gender 
11 7.0 Yorkshire Terrier FS 
s12 5.0 Rottweiler F 
13 11.0 Cavalier King Charles Spaniel  FS 
14 13.0 Mixed Breed FS 
15 3.0 Bernese Mountain Dog F 
16 6.0 Akita Inu M 
17 8.0 Rottweiler M 
18 8.0 Miniature Schnauzer M 
19 2.0 Yorkshire Terrier F 
20 2.0 Brazilian Terrier F 
21 1.0 Miniature Poodle F 
22 5.0 Mixed Breed M 
23 7.0 American Pit Bull Terrier M 
24 4.0 Boxer F 
25 9.0 Miniature Poodle F 
26 10.0 Mixed Breed F 
27 1.0 French Bulldog M 
28 1.5 Yorkshire Terrier F 
29 4.0 Lhasa Apso F 
30 1.0 Boxer M 
31 3.0 Mixed Breed F 
32 8.0 Whippet F 
33 5.0 Lhasa Apso M 
34 2.0 Yorkshire Terrier F 
35 1.5 Boxer F 
36 2.0 Maltese F 
37 12.0 Australian Shepherd FS 
38 8.0 English Bulldog FS 
39 10.5 Golden Retriever M 
40 5.0 Doberman Pinscher Mix MC 
41 8.0 Bichon Frise MC 
42 8.0 unknown MC 
43 7.0 Cocker Spaniel MC 
44 8.0 Rhodesian Ridge Back MC 
45 4.0 English Bulldog M 
46 1.3 Pomeranian Mix FS 
47 5.0 French Bulldog FS 
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Table 1. continued 
Number Age (years) Breed Gender 
48 8.5 Yorkshire Terrier FS 
49 7.8 Chinese Shar Pei M 
50 1.5 Boston Terrier Mix FS 
51 2.5 Labrador Retriever MC 
52 2.3 Springer Spaniel MC 
53 7.3 Miniature Poodle MC 
54 8.5 Parson Russel Terrier Mix FS 
55 8.8 Golden Retriever FS 
56 6.0 Shiba Inu MC 
57 1.3 Toy Poodle FS 
58 9.0 Cairn Terrier MC 
59 6.0 Boxer Mix MC 
60 1.3 Cocker Spaniel FS 
61 11.0 Labrador Retriever FS 
62 2.3 Shih Tzu FS 
63 17.0 Whippet Mix FS 
64 5.0 Chinese Shar Pei MC 
65 7.5 Newfoundland MC 
66 6.0 Siberian Husky Mix FS 
67 9.5 Cocker Spaniel Mix (Cockapoo) FS 
68 13.0 Boston Terrier FS 
69 1.5 Labrador Retriever FS 
70 8.0 Labrador Retriever FS 
71 4.0 German Shepherd Dog M 
72 1.5 Siberian Husky MC 
73 1.0 German Shepherd Dog F 
74 2.5 German Shepherd Dog M 
75 10.0 Staffordshire Bull Terrier MC 
76 3.0 Greyhound FS 
77 7.0 Basset Hound FS 
78 1.0 Mixed Breed M 
79 2.0 Labrador Retriever MC 
80 5.0 Border Collie M 
81 1.5 Cocker Spaniel M 
82 7.0 Lurcher FS 
83 4.0 Tibetan Terrier unknown 
84 2.0 Boxer unknown 
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Table 1. continued 
Number Age (years) Breed Gender 
85 10.0 Golden Retriever unknown 
86 7.0 Flat Coated Retriever unknown 
87 3.0 Labrador Retriever unknown 
88 5.0 Labrador Retriever unknown 
89 3.0 Yorkshire Terrier unknown 
90 2.0 German Shepherd Dog unknown 
91 4.0 Boxer unknown 
92 5.0 Standard Poodle unknown 
93 7.0 Golden Retriever unknown 
94 6.5 Golden Retriever unknown 
95 6.7 Border Terrier M 
96 7.6 Bichon Frise F 
97 4.4 Bull Mastiff F 
98 7.5 Drever unknown 
99 3.2 Labrador Retriever M 
100 5.8 Mixed Breed M 
101 3.8 Hungarian Vizsla M 
102 3.5 Shetland Sheepdog M 
103 0.8 Boxer M 
104 6.1 Papillon MC 
105 2.2 Miniature Poodle M 
106 2.0 Rottweiler FS 
107 3.9 Great Dane M 
108 7.0 Weimaraner F 
    
    Healthy dogs enrolled in the study 
1 8.0 Mixed Breed M 
2 3.0 Mixed Breed F 
3 6.0 Mixed Breed FS 
4 10.0 Rottweiler FS 
5 3.0 Miniature Pinscher FS 
6 11.0 Rottweiler F 
7 2.0 Mixed Breed FS 
8 1.5 Labrador Retriever MC 
9 1.0 Dachshund M 
10 7.0 Mixed Breed MC 
11 5.0 Dachshund M 
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Table 1. continued 
Number Age (years) Breed Gender 
12 3.0 German Shepherd Dog Mix FS 
13 1.5 Labrador Retriever FS 
14 2.0 Mixed Breed MC 
15 1.0 Siberian Husky MC 
16 6.0 Mixed Breed FS 
17 2.0 Zwergpinscher F 
18 5.0 Rhodesian Ridge Back M 
19 4.0 Parson Russel Terrier M 
20 6.0 Cocker Spaniel FS 
21 2.0 Beagle FS 
22 10.0 Rottweiler FS 
23 2.0 Mixed Breed FS 
24 2.5 Mixed Breed FS 
25 8.0 Maltese MC 
26 5.0 Pug FS 
27 2.0 Irish Water Spaniel M 
28 3.0 Doberman Pinscher FS 
29 13.0 Mixed Breed FS 
30 1.5 Miniature Pinscher MC 
31 4.0 Mixed Breed FS 
32 7.0 Chihuahua MC 
33 7.0 Mixed Breed MC 
34 4.0 Pug MC 
35 8.0 Cardigan Welsh Corgi MC 
36 2.0 Australian Shepherd FS 
37 2.0 Australian Shepherd FS 
38 1.5 Parson Russel Terrier FS 
39 12.0 Mixed Breed MC 
40 7.0 Golden Retriever M 
41 4.0 Hungarian Vizsla MC 
42 3.0 Mixed Breed MC 
43 6.0 Mixed Breed MC 
44 12.0 Mixed Breed MC 
45 7.0 Chihuahua MC 
46 11.0 Labrador Retriever MC 
47 5.0 Mixed Breed MC 
48 2.0 Mixed Breed FS 
49 4.0 Yorkshire Terrier MC 
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Table 1. continued 
Number Age (years) Breed Gender 
50 8.0 Australian Shepherd MC 
51 7.0 Mixed Breed FS 
52 4.0 German Shepherd Dog M 
53 6.0 Finnish Lapphund M 
54 3.0 Finnish Lapphund M 
55 2.0 Staffordshire Bull Terrier M 
56 9.0 Miniature Schnauzer FS 
57 3.0 Cavalier King Charles Spaniel  F 
58 4.0 Border Collie MC 
59 4.0 Whippet unknown 
60 4.0 Whippet F 
61 7.0 Whippet FS 
62 6.0 Whippet FS 
63 3.0 Australian Shepherd FS 
64 13.0 Australian Shepherd FS 
65 7.0 Flat Coated Retriever M 
66 1.5 Flat Coated Retriever M 
67 4.0 Flat Coated Retriever F 
68 4.0 Siberian Husky MC 
69 4.0 Dachshund M 
70 2.0 Dachshund M 
71 4.0 Mudi F 
72 4.0 German Shepherd Dog F 
73 2.0 Dachshund F 
74 1.5 Siberian Husky F 
75 5.0 Griffon Korthal M 
76 4.0 Canaan Dog FS 
77 5.0 Mixed Breed MC 
78 4.0 Parson Russel Terrier FS 
79 2.0 Australian Cattle Dog MC 
80 1.0 Australian Shepherd MC 
81 1.0 Siberian Husky M 
82 1.0 Miniature Pinscher F 
83 6.0 Mixed Breed FS 
84 9.0 Doberman Pinscher MC 
85 3.0 Mixed Breed MC 
86 2.0 Golden Retriever FS 
87 2.0 Mixed Breed FS 
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Table 1. continued 
Number Age (years) Breed Gender 
88 8.0 Siberian Husky Mix M 
89 13.0 Mixed Breed FS 
90 4.0 American Staffordshire Terrier M 
91 2.0 Golden Retriever F 
92 2.0 Golden Retriever M 
93 4.0 Weimaraner M 
94 10.0 Mixed Breed FS 
95 1.0 German Shepherd Dog M 
96 11.0 Pekinese FS 
97 6.0 Italian Greyhound FS 
98 3.0 Mixed Breed FS 
99 4.0 Miniature Poodle FS 
100 6.0 Labrador Retriever F 
101 5.0 White Shepherd Dog  F 
102 unknown Rottweiler FS 
103 5.0 Shetland Sheepdog FS 
104 8.0 Miniature Schnauzer M 
105 unknown English Pointer M 
106 6.0 Parson Russel Terrier FS 
107 15.0 Miniature Poodle M 
108 16.0 Dachshund M 
109 1.5 Whippet MC 
110 4.5 Rottweiler FS 
111 5.0 Mixed Breed FS 
112 8.0 Dachshund FS 
113 8.0 Mixed Breed MC 
114 1.0 Golden Retriever FS 
115 15.0 Yorkshire Terrier MC 
116 10.0 Bull Terrier MC 
117 3.0 Mixed Breed FS 
118 4.5 Mixed Breed MC 
119 12.0 German Shepherd Dog F 
120 11.0 Mixed Breed FS 
121 5.0 German Shepherd Dog MC 
122 1.0 Labrador Retriever Mix MC 
123 3.0 Boxer FS 
124 4.0 Australian Cattle Dog M 
125 2.0 American Pit Bull Terrier Mix FS 
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Table 1. continued 
Number Age (years) Breed Gender 
126 4.0 Australian Shepherd MC 
127 4.0 Mixed Breed FS 
128 3.0 Mixed Breed MC 
129 2.5 Red Heeler Mix FS 
130 3.0 Shih Tzu MC 
131 7.0 Miniature Schnauzer FS 
132 2.5 Bichon Frise FS 
133 3.0 Siberian Husky MC 
134 3.0 Malamute FS 
135 3.0 Labrador Retriever Mix FS 
136 4.0 Siberian Husky MC 
137 1.0 Basenji FS 
138 3.0 Australian Shepherd Mix FS 
139 1.5 Golden Retriever MC 
140 1.0 Border Collie FS 
141 unknown Australian Shepherd FS 
142 2.0 Labrador Retriever Mix FS 
143 2.5 Rough Collie Mix FS 
144 4.0 Yorkshire Terrier unknown 
145 1.0 Great Dane Mix MC 
146 1.0 Pembroke Welsh Corgi MC 
147 unknown unknown unknown 
148 2.0 Australian Kelpie F 
149 4.0 Mixed Breed FS 
150 4.0 Great Dane MC 
151 10.0 Labrador Retriever Mix FS 
152 2.0 Labrador Retriever Mix FS 
153 3.0 Labrador Retriever Mix MC 
154 2.0 Labrador Retriever FS 
155 1.0 Labrador Retriever FS 
156 2.0 Beagle F 
157 2.0 Labrador Retriever M 
158 5.0 Fox Terrier Mix FS 
159 4.0 West Highland White Terrier Mix M 
160 1.0 Pekingese MC 
161 3.0 American Pit Bull Terrier MC 
162 2.0 Mixed Breed FS 
163 1.0 Mixed Breed FS 
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Table 1. continued 
Number Age (years) Breed Gender 
164 1.5 Golden Retriever Mix (Goldendoodle) FS 
165 1.0 Boston Terrier MC 
166 2.0 English Mastiff MC 
167 1.0 Cardigan Welsh Corgi MC 
168 1.0 Belgian Shepherd Dog F 
169 3.5 Blue Lacy MC 
170 3.0 Australian Shepherd FS 
171 9.0 Labrador Retriever FS 
172 2.0 BlueTickCoonHound FS 
173 4.0 German Shepherd Dog Mix FS 
174 6.0 Cocker Spaniel FS 
175 1.0 Australian Shepherd MC 
176 5.0 Brittany Spaniel FS 
177 2.0 Boxer Mix FS 
178 7.0 Beagle Mix FS 
179 1.0 Mixed Breed MC 
180 1.0 American Pit Bull Terrier F 
181 3.0 Dalmatian FS 
182 2.0 Golden Retriever MC 
183 3.0 Catahoula Cur Mix FS 
184 7.0 Mixed Breed FS 
185 8.0 Mixed Breed FS 
186 5.0 Basset Hound MC 
187 3.0 Maltese FS 
188 5.0 German Shorthaired Pointer FS 
189 2.0 Red Heeler  Mix MC 
190 1.0 Labrador Retriever Mix MC 
191 2.0 Maltese M 
192 0.6 Newfoundland FS 
193 1.0 Australian Shepherd FS 
194 3.0 American Pit Bull Terrier MC 
195 1.0 Weimaraner Mix MC 
196 2.0 Labrador Retriever FS 
197 3.0 Labrador Retriever MC 
198 1.0 Tibetan Mastiff MC 
199 10.0 Miniature Schnauzer FS 
200 9.0 Weimaraner MC 
201 7.0 Weimaraner FS 
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Table 1. continued 
Number Age (years) Breed Gender 
202 1.0 American Pit Bull Terrier MC 
203 2.5 Labrador Retriever Mix FS 
204 4.0 Mixed Breed F 
205 5.5 German Shepherd Dog F 
206 5.0 Flat Coated Retriever F 
207 6.0 Belgian Shepherd Dog F 
208 3.0 Mixed Breed MC 
209 2.0 Boxer M 
210 2.0 Australian Cattle Dog FS 
211 8.0 Mixed Breed F 
212 3.0 Beagle MC 
213 7.0 Labrador Retriever FS 
214 3.5 Labrador Retriever F 
215 1.0 Labrador Retriever F 
216 9.0 Dachshund  MC 
217 9.0 Mixed Breed F 
218 1.0 Labrador Retriever F 
219 8.0 Mixed Breed MC 
220 1.5 Hovawart MC 
221 6.5 Mellan Pinscher F 
222 1.5 Dachshund MC 
223 1.5 Rhodesian Ridge Back M 
224 3.0 Mixed Breed MC 
225 8.0 Bull Mastiff M 
226 2.0 French Bulldog F 
227 4.0 Shih Tzu Mix MC 
228 5.0 Bloodhound M 
229 1.0 Bloodhound M 
230 6.0 Mixed Breed FS 
231 5.0 Cairn Terrier MC 
232 13.0 German Shepherd Dog Mix FS 
233 unknown Shih Tzu Mix MC 
234 4.0 American Pit Bull Terrier FS 
235 7.0 Miniature Pinscher MC 
236 2.0 Whippet  FS 
237 13.0 English Setter FS 
238 3.0 Belgian Shepherd Dog FS 
239 11.0 Mixed Breed FS 
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Table 1. continued 
Number Age (years) Breed Gender 
240 7.0 Boxer FS 
241 2.0 Mixed Breed MC 
242 7.0 Mixed Breed MC 
 
 
AHD = acute hemorrhagic diarrhea; CE = chronic enteropathies; MI = male intact; MC = 
male castrated; FI = female intact; FS = female spayed 
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 Quantitative PCR assays. Separate real-time qPCR assays were used to amplify 
and quantify DNA from eleven different microbial groups (Faecalibacterium spp., 
Turicibacter spp., Bifidobacterium spp., Lactobacillus spp., Streptococcus spp., 
Ruminococcaceae, C. perfringens, ɣ-Proteobacteria, Bacteroidetes, E. coli, and 
Firmicutes) using protocols and primers found in table 2.  A commercial qPCR thermal 
cycler (CFX96TM, Bio-Rad Laboratories, CA, USA) was used for all qPCR assays. 
SYBR-based reaction mixtures (total 10 μl) containing 5 μl SsoFastTM 
EvaGreen® supermix (Bio-Rad Laboratories, CA, USA), 2.6 μl of water, 0.4 μl of each 
primer (final concentration: 400 nM), and 2 μl of normalized DNA (final concentration: 
5 ng/μl). PCR conditions were 98 °C for 2 min, and 40 cycles at 98 °C 3 sec and 3 sec at 
the optimized annealing temperature (Table 2). A melt curve analysis was performed for 
SYBR-based qPCR assays as follows: 1 min at 95°C, 1 min at 55°C, and 80 cycles at 
0.5°C increments (5 sec each). Samples were analyzed in duplicate fashion. 
TaqMan® reaction mixtures (total 10 μl) containing 5 μl TaqMan® Fast 
Universal PCR master mix (Life Technologies, NY, USA) (2 x), 2 μl of water, 0.4 μl of 
each primer (final concentration: 400 nM), 0.2 μl of the probe (final concentration: 200 
nM), and 2 μl of normalized DNA.  PCR conditions were 95 °C for 20 sec, and 40 cycles 
at 95 °C for 5 sec, and 10 sec at the optimized annealing temperature (Table 2).  Samples 
were run in duplicate fashion. The qPCR data was expressed as amount of DNA (fg) for 
each particular bacterial group per 10 ng of isolated total DNA. 
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Table 2. Oligonucleotide primers/probe used for this study. 
qPCR 
primers/probe 
Sequence (5’- 3’) Target 
Annealing 
(°C) 
Reference 
CFB555f CCGGAWTYATTGGGTTTAAAGGG Bacteroidetes  60 [86] 
CFB968r GGTAAGGTTCCTCGCGTA 
   
Gamma395F CMATGCCGCGTGTGTGAA γ-Proteobacteria 69 [86] 
Gamma871R ACTCCCCAGGCGGTCDACTTA 
   
BifF TCGCGTCYGGTGTGAAAG Bifidobacterium spp. 60 [87] 
BifR CCACATCCAGCRTCCAC 
   
FaecaF GAAGGCGGCCTACTGGGCAC Faecalibacterium spp. 60 [88] 
FaecaR GTGCAGGCGAGTTGCAGCCT 
   
RumiF ACTGAGAGGTTGAACGGCCA 
Family 
Ruminococcaceae 
59 [88] 
RumiR CCTTTACACCCAGTAAWTCCGGA 
   
CPerf165F CGCATAACGTTGAAAGATGG       
CPerf269R CCTTGGTAGGCCGTTACCC C. perfringens 16S 58 [89] 
CPerf187F 
(probe) 
TCATCATTCAACCAAAGGAGCAATCC 
   
LacRT-f AGCAGTAGGGAATCTTCCAA Lactobacillus spp. 58 [90] 
LacRT-R CACCGCTACACATGGAG 
   
St1 TTATTTGAAAGGGGCAATTGCT Streptococcus spp. 54 [91] 
St2 GTGAACTTTCCACTCTCACAC  
   
EcolRT F GTTAATACCTTTGCTCATTGA E. coli 55 [87] 
EcolRT R ACCAGGGTATCTAATCCTGTT 
   
Firm350 F GGCAGCAGTRGGGAATCTTC Firmicutes 60 [86] 
Firm 814 R ACACYTAGYACTCATCGTTT 
   
TuriciF CAGACGGGGACAACGATTGGA Turicibacter 63 This study 
TuricR TACGCATCGTCGCCTTGGTA       
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 Statistical analysis. Data sets were tested for normal distribution using a 
D’Agostino & Pearson omnibus test. Since none of the datasets were normally 
distributed, non-parametric analyses were conducted.  For pairwise comparisons, Mann-
Whitney tests were used. For comparisons of disease groups, Kruskal-Wallis tests with 
Dunn’s post tests were used. All p-values were adjusted for multiple comparisons using 
the Bonferroni correction, and an adjusted p-value < 0.05 was considered significant. All 
statistical analyses were performed using Prism 4.00 (GraphPad Software, CA, USA). 
 
RESULTS 
To evaluate differences in the abundance of microbial groups among healthy 
dogs, dogs with CE, and dogs with AHD, all samples (242 healthy dogs, 118 dogs with 
CE, and 57 dogs with AHD) were analyzed for the abundance of sequences belonging to 
all 11 bacterial groups (Table 3, Figure 1). Faecalibacterium spp., Turicibacter spp., and 
Ruminococcaceae sequences were significantly decreased in CE and AHD compared to 
healthy dogs (p<0.001 for all). Lactobacillus spp. and Streptococcus spp. sequences 
were significantly increased in dogs with CE (p<0.001 for both) when compared to the 
healthy dogs. In contrast, Lactobacillus spp. and Streptococcus spp. sequences were 
significantly decreased in dogs with AHD compared to the healthy dogs (p<0.01 and 
p<0.05, respectively) and also the dogs with CE (p<0.001 for both). C. perfringens and 
E. coli sequences were significantly increased in dogs with AHD (p<0.001 and p<0.01, 
respectively), when compared to healthy dogs. E. coli sequences were also significantly 
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increased in dogs with CE when compared to the healthy dogs (p<0.001). Bacteroidetes 
sequences were significantly lower in dogs with CE compared to healthy dogs (<0.001).  
Firmicutes sequences were significantly higher in healthy dogs than in dogs with AHD 
(p<0.05). Bifidobacterium spp. and γ-Proteobacteria sequences were not significantly 
different among all three groups of dogs. 
Effect of antibiotic administration on the abundance of bacterial groups.  
Administration of antibiotics has been shown to significantly impact the gastrointestinal 
microbiota [77]. A subset of the dogs evaluated in this study had a history of antibiotic 
administration or were on antibiotics at the time of sample collection. To evaluate if the 
above observed changes were confounded by antibiotic administration, a subset analysis 
was performed on samples from those dogs from whom a complete antibiotic history 
was available. Fecal samples were evaluated from healthy dogs that either received 
(n=10) or did not receive (n=13) antibiotics within six months of sample collection, dogs 
with CE that either received (n=10) or did not receive (n=13) antibiotics within six 
months of sample collection, and dogs with AHD that either received (n=10) or did not 
receive (n=9) antibiotics within six months of sample collection (Table 4, Figure 2). 
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Table 3. Abundance of bacterial groups in fecal samples of healthy dogs, dogs with CE, 
and dogs with AHD based on qPCR analysis. 
 
            
 
 
Range (Minimum-Maximum) Medians   
  
Healthy 
(n=242) 
CE 
(n=108) 
AHD 
(n=57) 
Healthy CE AHD 
Adjusted 
Kruskal-
Wallis 
P-value* 
Faecalibacterium spp. 0.15-6.97 0.15-6.09 0.15-6.34 4.76a 2.46b 2.60b <0.0011 
Turicibacter spp. 0.90-7.83 0.11-6.93 0.900-6.05 4.94a 1.28b 1.25b <0.0011 
Bifidobacterium spp. 0.900-6.13 0.900-5.64 0.90-4.25 1.17 1.72 1.16 0.4081 
Lactobacillus spp. 1.27-6.69 1.38-6.53 1.38-4.80 2.53a 3.25b 2.25c <0.0011 
Streptococcus spp. 1.50-7.34 1.50-7.53 1.50-5.73 2.15a 3.47b 1.50c <0.0011 
Ruminococcaceae 1.90-7.99 1.99-7.67 1.99-7.72 6.83a 6.18b 5.97b <0.0011 
C. perfringens 0.44-11.05 0.49-10.99 0.49-12.86 3.55a 4.71a 6.25b <0.0011 
Y-Proteobacteria 1.71-7.96 2.16-7.70 2.16-7.06 3.31 3.85 3.60 1.0000 
Bacteroidetes 1.90-5.64 0.70-4.42 1.57-6.54 3.13a 1.90b 1.90a <0.0011 
E. coli 0.12-6.54 0.12-6.89 0.12-7.06 3.00a 4.19b 4.03b <0.0011 
Firmicutes 2.29-7.15 2.30-7.39 1.90-7.31 5.48a 5.57a 5.17b 0.1331 
Medians not sharing a common superscript indicates statistical significance based on Dunn’s multiple 
comparisons test; (P<0.05). 
CE = chronic enteropathies; AHD = acute hemorrhagic diarrhea 
   * Adjusted Kruskal-Wallis based on Bonferroni correction. Significance set at p<0.05. 
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Figure 1. Abundance of bacterial groups in healthy dogs, dogs with chronic enteropathies (CE), dogs 
with acute hemorrhagic diarrhea (AHD).  Significance was set at <0.05. 
 
 
 
Figure 1. Abundance of sequences belonging to 11 bacterial groups in fecal samples 
from healthy dogs, dogs with CE, and dogs with AHD based on qPCR analysis. 
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Table 4. Abundance of sequences of 11 bacterial groups in fecal samples from healthy dogs, dogs with CE, and dogs with AHD that either did or did not undergo administration of 
antibiotics within 6 months of sample collection. 
     
        
                    
 
Range (Minimum-Maximum) 
Medians   Dunn's Post-Test p-value 
  
Healthy 
without 
ABX 
(n=13) 
Healthy with 
ABX (n=10) 
CE without 
ABX 
(n=13) 
CE with 
ABX 
(n=10) 
AHD 
without 
ABX 
(n=9) 
AHD with 
ABX 
(n=10) 
Heal
thy 
with
out 
AB
X 
Healthy 
with 
ABX 
CE 
with
out 
ABX 
CE 
with 
ABX 
AHD 
without 
ABX 
AHD 
with 
ABX 
Adjusted 
Kruskal-
Wallis P-
value 
H 
without 
ABX 
vs H 
with 
ABX 
H 
without 
ABX 
vs CE 
without 
ABX 
H 
without 
ABX vs 
CE with 
ABX 
H 
without 
ABX 
vs 
AHD 
without 
ABX 
H 
without 
ABX 
vs 
AHD 
with 
ABX 
H with 
ABX 
vs CE 
without 
ABX 
H with 
ABX 
vs CE 
with 
ABX 
H with 
ABX 
vs 
AHD 
without 
ABX 
H with 
ABX 
vs 
AHD 
with 
ABX 
CE 
without 
ABX vs 
CE 
with 
ABX 
CE 
without 
ABX 
vs 
AHD 
without 
ABX 
CE 
without 
ABX 
vs 
AHD 
with 
ABX 
CE 
with 
ABX 
vs 
AHD 
without 
ABX 
CE 
with 
ABX 
vs 
AHD 
with 
ABX 
AHD 
without 
ABX 
vs 
AHD 
with 
ABX 
Faecalibacterium 2.28-6.53 2.30-5.92 0.15-5.77 0.15-4.22 0.15-4.22 0.15-4.31 5.25 4.63 2.19 1.99 4.03 0.66 0.0011* >0.05 <0.01* <0.01* >0.05 <0.01* >0.05 <0.05 >0.05 <0.05* >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Turicibacter 1.02-6.99 0.90-6.78 0.9-5.90 0.11-4.68 0.90-2.07 0.9-4.43 4.01 5.07 1.98 0.10 0.90 0.93 0.0011* >0.05 >0.05 >0.05 <0.05* >0.05 >0.05 <0.05* <0.01* <0.05* >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Bifidobacterium. 0.90-2.87 0.90-4.46 0.90-4.59 0.90-4.28 0.90-2.62 0.90-4.19 1.24 1.29 1.17 1.56 0.90 1.19 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Lactobacillus. 1.77-5.00 2.25-6.69 1.38-6.45 1.38-5.96 1.38-3.74 1.38-4.80 2.10 3.21 3.07 2.90 2.03 2.01 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Streptococcus. 1.50-4.95 1.50-6.52 1.50-6.92 1.50-7.01 1.50-4.30 1.50-4.56 1.50 4.05 2.53 2.65 1.50 1.82 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Ruminococcaceae 5.67-7.99 5.47-7.69 2.85-7.26 2.09-6.32 5.03-7.24 1.99-7.35 7.03 6.80 5.72 5.11 6.58 4.91 0.0033* >0.05 <0.05* <0.001* >0.05 >0.05 >0.05 <0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
C. perfringens 0.49-8.48 0.49-6.62 0.49-10.99 0.49-7.80 0.49-6.99 2.88-12.86 3.28 4.52 5.25 5.05 6.14 7.70 0.1386 >0.05 >0.05 >0.05 >0.05 <0.05* >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Y-Proteobacteria 2.16-5.71 2.97-7.96 2.16-5.88 2.16-7.52 2.16-7.06 2.16-6.17 3.28 4.07 2.96 4.60 2.81 3.40 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Bacteroidetes 1.90-4.75 1.90-5.16 1.90-4.42 1.90-3.57 1.90-4.60 1.90-4.40 3.39 3.08 2.01 1.90 3.49 2.29 0.4103 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
E. coli 0.12-5390 0.12-6.54 0.12-6.89 0.12-6.84 0.12-7.06 0.12-6.38 2.48 4.68 4.00 5.05 3.00 4.18 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
Firmicutes 4.56-6.15 3.86-7.15 2.35-7.39 2.30-6.65 2.82-5.88 1.90-6.13 5.38 5.94 5.45 4.81 5.25 4.78 1.0000 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 
                             
* Indicates statistical significance (P<0.05). 
                    
H = healthy; CE = chronic enteropathies; AHD = acute hemorrhagic diarrhea; ABX = antibiotics 
               Adjusted Kruskal-Wallis based on Bonferroni correction.                 
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Figure 2. Abundance of sequences of 11 bacterial groups in fecal samples from healthy 
dogs, dogs with CE, and dogs with AHD that did or did not undergo antibiotic 
administration within 6 months of sample collection. Significance set at <0.05. Please 
note difference in y-axis enumeration for graphs illustrating the abundance of 
Ruminococcaceae or C. perfringens log DNA. 
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Figure 2. Continued.
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Overall, there was no significant difference in bacterial abundance among 
healthy dogs and healthy dogs that received antibiotics within six months of sample 
collection (Table 5). Furthermore, antibiotic influence in dogs with CE and dogs with 
AHD was examined to validate results seen previously. Fecal samples from dogs from 
all 3 groups of dogs that did not receive antibiotics were compared among the 3 groups 
(Table 6). Additionally, fecal samples from all 3 groups of dogs that did receive 
antibiotics were compared among the 3 groups (Table 7). 
History of diarrhea. In order to assess if a previous episode of diarrhea in 
otherwise healthy dogs might significantly impact the GI microbiota, the fecal 
microbiota of healthy dogs with a history of diarrhea during the 6 months prior to sample 
collection (n=30) were compared to that of healthy dogs without a history of diarrhea 
during this time period (n=212) (Table 8, Figures 3 and 4). Faecalibacterium spp. 
sequences were significantly more abundant (p=0.0133) and C. perfringens were 
significantly less abundant (p=0.0156) in healthy dogs without a history of diarrhea than 
in those dogs with such a history of diarrhea. 
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Table 5. Abundance of sequences of 11 bacterial groups in fecal samples from healthy dogs that did 
not receive antibiotics and healthy dogs that received antibiotics within 6 months of sample collection. 
 
    
  
    
  
 Range (Minimum-Maximum) Medians 
 
  
  
  
Healthy 
without ABX 
(n=217) 
Healthy with 
ABX (n=25) 
Healthy 
without 
ABX 
Healthy 
with ABX 
Mann-
Whitney P-
value 
Adjusted 
Mann-
Whitney P-
value 
  Faecalibacterium 
spp. 
0.15-6.97 1.56-6.11 4.77 4.77 0.4954 
   Turicibacter spp. 0.90-7.83 0.90-6.90 4.94 5.14 0.5503 
   Bifidobacterium spp. 0.90-6.13 0.90-5.18 1.13 1.28 0.6508 
   Lactobacillus spp. 1.27-6.18 1.38-6.69 2.48 2.85 0.2293 
   Streptococcus spp. 1.50-7.34 1.50-6.52 2.07 2.42 0.7697 
   Ruminococcaceae 1.90-7.99 5.47-7.72 6.84 6.98 0.814 
   C. perfringens 0.44-11.05 0.49-6.62 3.49 4.34 0.3907 
   Y-Proteobacteria 1.71-6.80 2.16-7.96 3.28 4.11 0.0317* 0.3487 
  Bacteroidetes 1.90-5.64 1.90-5.16 3.14 2.98 0.5214 
   E. coli 0.12-6.40 0.12-6.54 2.85 4.26 0.0111 
   Firmicutes 2.29-7.07 3.51-7.15 5.46 5.52 0.2959   
  
         * Indicates statistical significance (P<0.05). 
ABX = antibiotics 
        Adjusted p-values based on Bonferroni correction. Significance set at p<0.05. 
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Table 6. Abundance of sequences of 11 bacterial groups in fecal samples from healthy dogs, dogs with 
CE, and dogs with AHD that did not receive antibiotics within 6 months of sample collection. 
 
      
 
      
  
 Range (Minimum-Maximum) Medians   
  
  
Healthy 
without 
ABX 
(n=217) 
CE without 
ABX 
(n=87) 
AHD 
without 
ABX 
(n=49) 
Healthy 
without 
ABX 
CE without 
ABX 
AHD 
without 
ABX 
Adjusted 
Kruskal-
Wallis P-
value* 
  Faecalibacterium 
spp. 0.15-6.97 0.15-6.09 0.15-6.34 4.77
a 2.45b 2.69b <0.0011 
  Turicibacter spp. 0.90-7.83 0.11-6.93 0.90-6.05 4.94a 1.49b 1.30b <0.0011 
  Bifidobacterium 
spp. 0.90-6.13 0.90-5.64 0.90-4.25 1.13 1.64 1.09 1.0000 
  Lactobacillus 
spp. 1.27-6.18 1.38-6.53 1.38-4.28 2.48
a 3.20b 2.25c <0.0011 
  Streptococcus 
spp. 1.50-7.34 1.50-7.53 1.50-5.79 2.07
a 3.44b 1.52c <0.0011 
  Ruminococcaceae 1.90-7.99 1.99-7.67 1.99-7.72 6.84a 6.10b 6.12b <0.0011 
  C. perfringens 0.44-11.05 0.49-10.99 0.49-8.53 3.49a 4.80a 6.17b <0.011 
  Y-Proteobacteria 1.71-6.80 2.16-7.70 2.16-7.06 3.28 3.86 3.61 1.0000 
  Bacteroidetes 1.90-5.64 1.75-4.42 1.57-6.54 3.14
a 1.90b 3.21a <0.0011 
  E. coli 0.12-6.40 0.12-6.89 0.12-7.06 2.85a 4.15b 3.96b <0.0011 
  Firmicutes 2.29-7.07 2.35-7.39 2.52-7.31 5.46
ab 5.51a 5.19b 0.5258 
  
          Medians not sharing a common superscript indicates statistical significance (p<0.05, Dunn’s multiple comparisons test). 
 CE = chronic enteropathies; AHD = acute hemorrhagic diarrhea; ABX = antibiotics 
    * Adjusted Kruskal-Wallis based on Bonferroni correction. Significance set at p<0.05. 
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Table 7. Abundance of sequences of 11 bacterial groups in fecal samples from healthy dogs, dogs with CE, 
and dogs with AHD that did receive antibiotics within 6 months of sample collection. 
 
      
 
      
  
 Range (Minimum-Maximum) Medians   
  
  
Healthy 
with ABX 
(n=25) 
CE with 
ABX 
(n=21) 
AHD with 
ABX (n=8) 
Healthy 
with ABX 
CE with 
ABX 
AHD with 
ABX 
Adjusted 
Kruskal-
Wallis P-
value* 
  Faecalibacterium spp. 0.16-6.11 0.15-5.87 0.15-4.31 4.75a 2.15b 0.66b <0.0011 
  Turicibacter spp. 0.90-6.90 0.90-4.68 0.90-4.43 5.14a 0.90b 0.90b <0.0011 
  Bifidobacterium spp. 0.90-5.18 0.90-5.30 0.90-4.19 1.28 1.76 1.19 1.0000 
  Lactobacillus spp. 1.38-6.69 1.38-6.43 1.38-4.80 2.85 3.65 2.01 1.0000 
  Streptococcus spp. 1.50-6.52 1.50-7.20 1.50-4.56 2.42 4.05 1.82 1.0000 
  Ruminococcaceae 5.47-7.72 2.09-7.08 1.99-7.35 6.98a 6.20b 4.91ab 0.0704 
  C. perfringens 0.49-6.62 0.49-7.80 2.88-12.86 4.34a 4.27a 7.70b 0.0209 
  Y-Proteobacteria 2.16-7.96 2.16-7.52 2.16-6.17 4.11 3.82 3.40 1.0000 
  Bacteroidetes 1.90-5.16 0.70-4.03 1.90-4.40 2.98
a 1.90b 1.90ab 0.1364 
  E. coli 0.12-6.54 0.12-6.85 0.12-6.38 4.26 4.43 4.18 1.0000 
  Firmicutes 3.51-7.15 2.30-7.08 1.90-6.13 5.52 5.55 4.78 0.3476 
  
          Medians not sharing a common superscript indicates statistical significance (p<0.05, Dunn’s multiple comparisons test). 
 CE = chronic enteropathies; AHD = acute hemorrhagic diarrhea; ABX = antibiotics 
    * Adjusted Kruskal-Wallis based on Bonferroni correction. Significance set at p<0.05.. 
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Table 8. Abundance of sequences of fecal bacterial groups of healthy dogs without a history of diarrhea in the 6 
months prior to sample collection and in dogs with CE or AHD. 
 
              
    
 Range (Minimum-Maximum) Medians 
     
  
Healthy 
without D 
(n=212) 
CE (n=108) 
AHD 
(n=57) 
Healthy 
without D 
CE AHD 
Adjusted 
Kruskal-
Wallis P-
value* 
    Faecalibacterium spp. 0.15-6.97 0.15-6.09 0.15-6.34 4.83a 2.40b 2.64b <0.0011 
    Turicibacter spp. 0.90-7.83 0.11-6.93 0.90-6.05 4.95a 1.29b 1.26b <0.0011 
    Bifidobacterium spp. 0.90-6.13 0.90-5.64 0.90-4.25 1.13a 1.72b 1.16ab 0.2266 
    Lactobacillus spp. 1.27-6.69 1.38-6.53 1.38-4.80 2.52a 3.25b 2.25c <0.0011 
    Streptococcus spp. 1.50-7.34 1.50-7.53 1.50-5.79 2.19a 3.47b 1.50c <0.0011 
    Ruminococcaceae 1.90-7.99 1.99-7.67 1.99-7.72 6.83a 6.18b 5.97b <0.0011 
    C. perfringens 0.44-11.05 0.49-10.99 0.49-12.86 3.47a 4.70a 6.25b <0.0011 
    Y-Proteobacteria 2.02-7.96 2.16-7.70 2.16-7.06 3.29 3.85 3.60 1.0000 
    Bacteroidetes 1.90-5.64 0.70-4.42 1.57-6.54 3.12
a 1.90b 2.99a <0.0011 
    E. coli 0.12-6.54 0.12-6.89 0.12-7.06 2.96a 4.19b 4.03b <0.0011 
    Firmicutes 2.31-7.15 2.30-7.39 1.90-7.31 5.48
a 5.57a 5.17b 0.1265 
    
            Medians not sharing a common superscript indicates statistical significance (p<0.05). 
    D = diarrhea; CE = chronic enteropathies; AHD = acute hemorrhagic diarrhea; 
      * Adjusted Kruskal-Wallis based on Bonferroni correction. Significance set at p<0.05. 
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Figure 3. Abundance of C.perfringens in healthy dogs without diarrhea in the 6 months 
prior to sample collection (“healthy dogs without hx of diarrhea”) and in healthy dogs 
with such a history of diarrhea (“healthy dogs with hx of diarrhea”) during this period. 
Significance set at <0.05. 
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Figure 4. Abundance of Faecalibacterium spp. in healthy dogs without diarrhea in the 6 
months prior to sample collection (“healthy dogs without hx of diarrhea”) and in healthy 
dogs with such a history of diarrhea (“healthy dogs with hx of diarrhea”) during this 
period. Significance set at <0.05. 
 
 
0.0133 
Healthy Healthy with 
history of diarrhea 
Healthy dogs 
without hx of 
diarrhea 
ealthy dogs 
with hx of 
diarrhea 
 48 
Dietary macronutrients. It has been shown that dietary components such as 
protein, fat, and fiber can alter the GI microbiota and it is possible that healthy dogs and 
dogs with CE in this study were fed different amounts of these dietary components, 
thereby potentially confounding our results  [7,65,92]. In order to compare dietary 
macronutrients among all 3 groups of dogs, the percent metabolizable energy (ME) from 
protein, fat, and carbohydrates  were compared separately among healthy dogs (n=65) 
and dogs with CE (n=57) (Table 9, Figure 5.). A significant difference was observed in 
the percent metabolizable energy from protein between healthy dogs and dogs with CE 
(p=0.0032). Dietary macronutrients in healthy dogs ranged from 15-38 % metabolizable 
protein, whereas dietary macronutrients in dogs with CE ranged from 15-37 % 
metabolizable protein, with medians of 25 and 24, respectively (Table 9). 
In order to evaluate a potential confounding effect of the dietary protein source, 
the bacterial abundances for all 11 groups were compared among healthy dogs known to 
be consuming a diet with a primary protein source of poultry (n=69) to healthy dogs that 
were consuming a diet with a primary protein source other than poultry (n=32). Overall 
no significant differences were found for any of the groups analyzed (Table 10).  
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Table 9. Macronutrient content in the diets fed to healthy dogs and dogs with chronic enteropathies. 
        
 
Range (Minimum-
Maximum) 
Medians 
   
  healthy (n=65) 
chronic 
enteropathies 
(n=57) 
healthy 
chronic 
enteropathies 
Mann-
Whitney P-
value 
Adjusted 
Mann-
Whitney P-
value 
 %ME protein 15.00-38.00 15.00-37.00 25.00 24.00 0.0032* 0.0352* 
 %ME fat 14.90-57.30 19.40-39.00 31.00 29.50 0.6626 
  %ME carbohydrate 14.9-59.00 33.00-55.90 46.00 47.00 0.1662   
 
        * Indicates statistical significance (P<0.05). 
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Figure 5. Percent metabolizable energy (ME) from protein, fat, and carbohydrates in 
diets of healthy dogs compared to those fed to dogs with chronic enteropathies (CE). 
Significance set at <0.05. 
 
0.0032 
0.6626 
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Table 10. Abundance of bacterial groups in fecal samples of healthy dogs 
fed poultry-based diets and healthy dogs with diets based on other protein 
sources. 
  
        
 
Range (Minimum-
Maximum) 
Medians   
  
  
Healthy 
dogs fed 
poultry 
(n=69) 
Healthy 
dogs fed 
other protein 
(n=32) 
Healthy 
dogs fed 
poultry 
Healthy 
dogs fed 
other 
protein 
Mann-
Whitney P-
value 
  Faecalibacterium spp. 1.33-6.97 0.15-6.72 4.62 4.66 0.208 
  Turicibacter spp. 0.90-7.83 0.90-7.58 4.82 4.98 0.5716 
  Bifidobacterium spp. 0.90-5.64 0.90-5.87 0.90 0.90 0.6922 
  Lactobacillus spp. 1.38-5.94 1.38-5.78 2.19 2.47 0.3851 
  Streptococcus spp. 1.50-6.93 1.50-7.34 1.50 3.00 0.2296 
  Ruminococcaceae 1.90-7.73 4.89-7.54 6.76 6.99 0.1076 
  C. perfringens 0.49-11.05 0.49-10.45 3.40 2.96 0.8637 
  Y-Proteobacteria 2.02-7.96 2.16-6.29 2.82 2.71 0.6905 
  Bacteroidetes 1.90-5.13 1.90-4.75 3.02 2.88 0.5966 
  E. coli 0.12-6.54 0.12-6.40 2.43 2.52 0.1374 
  Firmicutes 2.29-6.68 2.31-6.50 5.42 5.49 0.7731 
   
* Indicates statistical significance (P<0.05). 
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The abundances of sequences for all 11 groups were also compared among dogs 
with CE known to be consuming a diet with a primary protein source of poultry (n=27) 
to dogs with CE that were consuming a diet with a primary protein source other than 
poultry (n=35) (Table 11). Those dogs consuming a diet with a primary source of poultry 
had a significantly lower abundance of E. coli (median 3.13, range  0.12-6.25) compared 
to dogs being fed other primary protein sources (median 4.40, range  0.12-6.24; 
p=0.0458), No significant differences were observed for any of the other bacterial 
groups. 
DISCUSSION 
Previous studies have used sequencing-based methods to describe the intestinal 
microbiota of healthy dogs and have revealed a highly complex intestinal ecosystem, 
comprising several hundred to thousand bacterial phylotypes [21,63,75].  Those studies 
have shown that Firmicutes and Bacteroidetes are typically the most abundant phyla 
representing up to 90% of sequences of the canine fecal microbiota. Other important 
phyla are Fusobacteria, Proteobacteria, and Actinobacteria with reported abundances 
ranging between 0 – 30% in various studies [21,63,75]. Firmicutes and Bacteroidetes  
are considered of importance to gastrointestinal health as they include several 
phylogenetic bacterial groups that synthesize various metabolites, including short-chain 
fatty acids [6]. Short-chain fatty acids (SCFA), especially butyrate, provide nutritional 
benefits to the host, provide energy for epithelial cell growth, and have been shown to 
have anti-inflammatory and immune-modulatory properties [6]. They also regulate the 
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luminal pH in the intestine, a mechanism that may help in the exclusion of potentially 
invading pathogens.  
Gastrointestinal diseases in both humans and dogs have been associated with an 
altered composition of the intestinal microbiota. Most commonly observed changes 
include a decrease in members of Firmicutes and Bacteroidetes, and increases in 
members of Proteobacteria [21,75,76,93]. For example, Frank et al [93] described the 
microbiota of humans with inflammatory bowel disease (i.e., Crohn’s disease and 
ulcerative colitis). The sequence based analysis of resected tissue samples from diseased 
individuals and healthy controls revealed depletion in the phylum Firmicutes and 
Bacteroidetes, and an increase in Proteobacteria  in humans with IBD [93]. Similarly, 
recent studies analyzing the small intestinal microbiota of dogs with IBD have revealed 
similar patterns of dysbiosis as those observed in human ileal samples [21,75].  
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Table 11. Abundance of bacterial groups in fecal samples of dogs with CE fed poultry-based diets 
and dogs with CE with diets based on other protein sources. 
        
 
Range (Minimum-
Maximum) 
Medians       
 
  
CE dogs 
fed poultry 
(n=27) 
CE dogs fed 
other protein 
(n=35) 
CE dogs 
fed poultry 
CE dogs 
fed other 
protein 
Mann-
Whitney P-
value 
Adjusted 
Mann-
Whitney P-
value 
 Faecalibacterium spp. 0.15-6.09 0.15-5.87 2.33 2.31 0.7655 
 
 Turicibacter spp. 0.90-6.93 0.11-5.60 1.15 1.61 0.6633 
 
 Bifidobacterium spp. 0.90-5.39 0.90-4.59 1.24 1.56 0.983 
 
 Lactobacillus spp. 1.38-6.43 1.38-6.53 3.35 3.25 0.8983 
 
 Streptococcus spp. 1.50-7.53 1.50-7.05 3.15 4.80 0.4465 
 
 Ruminococcaceae 1.99-7.63 3.26-7.67 6.60 6.20 0.7765 
 
 C. perfringens 0.49-10.99 0.49-10.17 4.98 4.52 0.9207 
 
 Y-Proteobacteria 2.16-6.61 2.16-7.70 2.88 3.49 0.6385  
 Bacteroidetes 0.70-3.58 1.90-4.03 1.90 1.90 0.1311  
 E. coli 0.12-6.25 0.12-6.24 3.13 4.40 0.0485* 0.5335 
 Firmicutes 2.35-7.25 4.00-6.98 5.64 5.56 0.5994   
  
* Indicates statistical significance (P<0.05). 
CE = chronic enteropathies 
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Little information is available about the fecal microbiota of dogs with acute or 
chronic gastrointestinal diseases. One question of particular interest is whether the bacterial 
dysbiosis in the small intestine of dogs with IBD can also be identified in fecal samples, and 
also whether specific patterns of dysbiosis are specific for specific GI disease. Therefore, for 
the purposes of this study, we compared a sample population of healthy dogs to dogs with 
acute or chronic gastrointestinal disease. While molecular-based sequencing techniques are 
useful tools for evaluating the entire microbiota, this approach is rather expensive. 
Therefore, in this study, the fecal microbiota of healthy dogs, dogs with chronic 
enteropathies (CE), and dogs with acute hemorrhagic diarrhea (AHD) was characterized 
using qPCR analysis. The bacterial groups evaluated were chosen because they had 
previously been found to be altered in humans or dogs with GI disease..   
The results of this study indicate that dogs with CE or AHD have an altered 
composition of the intestinal microbiota when compared to healthy dogs. Furthermore, 
significant differences in the abundances of sequences of specific bacterial groups were 
also observed between dogs with CE and dogs with AHD. This would suggest that the 
duration of illness, as well as other differences in the disease processes influence the 
composition of the intestinal microbiota. 
The abundances of sequences of several bacterial groups were significantly 
different between dogs with CE and healthy dogs. Most notably Bacteroidetes and 
members of Firmicutes (i.e., Faecalibacterium spp., Ruminococcaceae, and Turicibacter 
spp.) were decreased in abundance in dogs with CE. These bacterial groups are 
considered short-chain fatty acid producers and a decrease in these bacterial groups may 
potentially have a significant impact on the luminal concentrations of these metabolites. 
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Further studies are needed to correlate fecal concentrations of SCFA and the abundances 
of these bacterial groups. Similar decreases have also been previously observed in fecal 
samples of humans with IBD [54]. We observed a trend for an increased abundance of 
Proteobacteria sequences, including E. coli, in dogs with CE compared to healthy dogs, 
but this increase was not significant. In previous studies fecal samples of humans with 
IBD and duodenal samples of dogs with IBD were shown to have a significantly 
increased abundance of these bacterial groups [21,73,75,76]. 
Significant differences in the abundance of several bacterial groups were 
observed between healthy dogs and dogs with AHD. Similar to dogs with CE, dogs with 
AHD also had a significantly increased abundance of sequences of members of 
Firmicutes, including Faecalibacterium spp., Ruminococcaceae, and Turicibacter spp. 
However, Lactobacillus spp. and Streptococcus spp., also members of the Firmicutes, 
showed a significant decreased abundance in dogs with AHD, but not in CE, when 
compared to control dogs. This would suggest that the dysbiosis is potentially more 
pronounced in acute hemorrhagic disease, as more bacterial groups are depleted. All 
these bacterial groups are considered important bacterial groups in the normal canine GI 
tract, as they produce SCFA (e.g., Faecalibacterium spp., Ruminococcaceae) or lactic 
acids (e.g., Lactobacillus spp. and Streptococcus spp), all of which are important 
metabolites that help maintain homeostasis of the physiiologic intestinal microbiota. In 
contrast, the abundances of C. perfringens and E. coli were significantly increased in 
dogs with AHD. This increase in abundance of the gram-negative E. coli is not 
surprising, as increases of members of the phylum Proteobacteria have been commonly 
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associated with intestinal inflammation [21,75,93]. Furthermore, it has been well 
established that specific strains of E. coli (i.e., enteropathogenic, enterotoxigenic, 
enterohemorrhagic, or enteroinvasive) can induce gastrointestinal inflammation in dogs 
[94]. Similarly, enterotoxin-producing C. perfringens has been linked to GI disease in 
dogs [80,94].  The increased abundance of C. perfringens and E. coli observed in this 
study may be due to strains containing virulence factors, which were not evaluated in 
this study, but these virulence factors warrant further studies.  
Dogs that were considered healthy at the time of sample collection, but that had a 
history of diarrhea within the past six months before sample collection had a decreased 
abundance of Faecalibacterium spp. (p=0.0133) and an increased abundance of C. 
perfringens (p=0.0156) in comparison to healthy dogs with no history of diarrhea in said 
time period. Although, these differences were not significantly different after p-values 
were adjusted for multiple comparisons, these results suggest some interesting aspects of 
dysbiosis that should be evaluated in further studies. It is possible that after episodes of 
diarrhea, longer periods than 6 months are required for Faecalibacterium spp, and C. 
perfringens to return to abundances that are comparable to healthy dogs. Follow-up 
longitudinal studies with multiple sample collections would be interesting to evaluate the 
time needed for the abundances of bacterial groups to normalize after episodes of 
diarrhea.  
We analyzed several potentially confounding factors in this study that may 
impact the abundances of specific bacterial groups. Administration of antibiotics has 
been shown to significantly impact the gastrointestinal microbiota [95]. For each disease 
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group, we therefore compared the abundances of bacterial groups among dogs that 
received antibiotics within 6 months of sample collection to those that did not receive 
antibiotics. These results suggest that antibiotic administration did not have an overall 
significant influence on the results observed in this study.  
Dietary components such as protein, fat, and fiber may also alter the GI 
microbiota and it is possible that healthy dogs and dogs with CE were fed different 
amounts of these dietary components in this study, thereby potentially confounding our 
results  [7,65,92]. We observed a significant difference in percent metabolizable energy 
from protein between the diets fed to the healthy dogs and dogs with CE. However, these 
differences were rather small. Dietary protein in the diets fed to healthy dogs ranged 
from 15-38% (median: 25%) of metabolizable energy, whereas it ranged from 15-37% 
(median: 24%) metabolizable energy in dogs with CE. Previous studies have shown that 
large differences in the dietary protein content are needed to induce even slight changes 
in selected bacterial groups such as C. perfringens and Bifidobacterium spp. [96].  
In conclusion, using qPCR analysis, dysbiosis was identified in fecal samples of 
dogs with CE or AHD. A decreased abundance of bacterial groups such as specific 
members of Firmicutes (i.e., Faecalibacterium spp, and Ruminococcaceae) may lead to 
decreased abundances of beneficial metabolites such as short-chain fatty acids. 
Therefore, future studies need to evaluate the luminal concentrations of SCFA in fecal 
samples of diseased dogs. 
 
 
 59 
CHAPTER III 
CONCLUSIONS 
 Previous studies have used sequencing-based methods to describe the intestinal 
microbiota of healthy dogs and have revealed a highly complex intestinal ecosystem, 
comprising several hundred to thousand bacterial phylotypes [21,63,75]. It has been 
suggested that alterations in the fecal microbiota have been implicated in the 
pathogenesis of GI disease in dogs [21,75,83,85]. Firmicutes (i.e., Faecalibacterium 
spp., Ruminococcaceae, and Turicibacter spp.) and Bacteroidetes  are considered to be 
important for GI health as they include several phylogenetic bacterial groups that 
synthesize various metabolites, including short-chain fatty acids, which are believed to 
provide the host with several beneficial properties [6]. 
 The results of this study indicate that dogs with CE as well as dogs with AHD 
have an altered composition of the intestinal microbiota when compared to healthy dogs. 
The abundances of several bacterial groups were significantly different between 
dogs with CE and healthy dogs. Most notably, the abundance of Bacteroidetes and 
members of Firmicutes (i.e., Faecalibacterium spp., Ruminococcaceae, and Turicibacter 
spp.) were decreased in dogs with CE. These bacterial groups are considered short-chain 
fatty acid producers and a decrease in these bacterial groups may potentially have a 
significant impact on the luminal concentrations of these metabolites. Future studies are 
needed to correlate fecal concentrations of SCFA and the abundances of these bacterial 
groups. 
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Significant differences in the abundance of several bacterial groups were 
observed between healthy dogs and dogs with AHD. Similar to dogs with CE, dogs with 
AHD also had a significantly increased abundance of members of Firmicutes, including 
Faecalibacterium spp., Ruminococcaceae, and Turicibacter spp. However, abundance of 
Lactobacillus spp. and Streptococcus spp., which are also members of the Firmicutes, 
were significantly decreased in dogs with AHD, but not in those with CE, when 
compared to healthy control dogs. This would suggest that the dysbiosis is potentially 
more pronounced in dogs with acute hemorrhagic disease, as more bacterial groups are 
depleted. 
In this study we compared a sample population of healthy dogs to dogs with 
acute or chronic gastrointestinal disease. While molecular-based sequencing 
technologies are very useful for evaluating the entire microbiota, this approach is rather 
expensive. Therefore, in this study, the fecal microbiota of healthy dogs, dogs with 
chronic enteropathies (CE), and dogs with acute hemorrhagic diarrhea (AHD) was 
characterized using qPCR analysis. Using these methods, a dysbiosis was identified in 
fecal samples of dogs with CE and AHD. A decreased abundance of bacterial groups 
such as specific members of Firmicutes (i.e., Faecalibacterium spp, and 
Ruminococcaceae) may lead to decreased concentration of beneficial metabolites such 
as short-chain fatty acids. Therefore, future studies need to evaluate luminal 
concentrations of SCFA in fecal samples of diseased dogs. 
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